Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 5Completed 3Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Other hematologic neoplasm 4Thoracic 3Lymphoid 3Other solid neoplasm 2Other 2Genitourinary 2Other neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Hematologic Neoplasms 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Exercise Test × Thoracic × Clear all
NCT05106374 2026-04-13

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Completed
182 enrolled
Other hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Hematologic Neoplasms

NCT04954885 2025-01-27

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Ohio State University Comprehensive Cancer Center

Completed
2 enrolled
Thoracic

Lung Neoplasms

NCT04676009 2024-02-21

ERICA

Centre Leon Berard

Phase NA Completed
26 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡